- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
A comment on the International Society of Geriatric Oncology guidelines: Evidence-based advice for the clinical setting - Abstract
October 26, 2012
The role of enzalutamide in the treatment of castration-resistant prostate cancer - Abstract
October 26, 2012
A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: Implications for PSA testing - Abstract
October 26, 2012
Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum - Abstract
October 26, 2012
African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center - Abstract
October 26, 2012
The efficacy of degarelix on LUTS (Lower urinary tract symptoms) relief in patients with 
prostate cancer - Abstract
October 26, 2012
Detection of prostate cancer by sialic acid level in patients with non-diagnostic levels of prostate-specific antigen - Abstract
October 25, 2012
In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer - Abstract
October 25, 2012
An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account - Abstract
October 25, 2012
A multiplex assay to measure RNA transcripts of prostate cancer in urine - Abstract
October 25, 2012
Is radical prostatectomy a useful therapeutic option for high-risk prostate cancer in older men? - Abstract
October 25, 2012
First web-based prostate cancer database launches to help new patients manage care, avoid complications
October 24, 2012
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence - Abstract
October 24, 2012